Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$84.74
pos +0.08
+0.09%
Today's Range: 84.51 - 85.53 | LLY Avg Daily Volume: 3,520,700
Last Update: 07/24/17 - 4:03 PM EDT
Volume: 3,947,306
YTD Performance: 15.11%
Open: $84.66
Previous Close: $84.66
52 Week Range: $64.18 - $86.72
Oustanding Shares: 1,103,388,743
Market Cap: 92,938,433,823
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 10 11
Moderate Buy 1 1 1 1
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.81 1.81 1.81 1.76
Latest Dividend: 0.52
Latest Dividend Yield: 2.45%
Dividend Ex-Date: 08/11/17
Price Earnings Ratio: 40.94
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
40.94 40.70 30.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.38% 5.30% 33.03%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.30 -0.10 -0.03
Net Income 13.70 -0.40 -0.16
EPS 14.20 -0.40 -0.16
Earnings for LLY:
EBITDA 5.34B
Revenue 21.22B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $1.04 $1.04 $4.12 $4.42
Number of Analysts 8 6 10 10
High Estimate $1.06 $1.08 $4.15 $4.66
Low Estimate $1.00 $1.00 $4.09 $4.29
Prior Year $0.86 $0.88 $3.52 $4.12
Growth Rate (Year over Year) 20.78% 18.56% 17.02% 7.31%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Jul 24, 2017 | 1:00 PM EDT
Aratana Therapeutics and Kindred Biosciences are promising drug developers in the pet space.
RMPIA
By

Jim Cramer

 | Jul 12, 2017 | 3:11 PM EDT
Days like this remind you why you stay in.
RMPIA
By

Jim Cramer

 | Jun 23, 2017 | 6:37 AM EDT
It just isn't as useful or descriptive right now.
By

Jim Cramer

 | Jun 16, 2017 | 5:58 AM EDT
A rotation that started as the minor chord of the rotational symphony and is now the major one.
RMPIA
By

Jim Cramer

 | Jun 15, 2017 | 7:31 AM EDT
We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.
RMPIA
By

Jim Cramer

 | Jun 7, 2017 | 7:29 AM EDT
The handwringers will be out in full force. Their fear creates buying opportunities.
By

Bruce Kamich

 | May 30, 2017 | 1:51 PM EDT
Struggling stock is downgraded.
RMPIA
By

Doug Kass

 | May 23, 2017 | 3:44 PM EDT
"There are two kinds of spurs, my friend. Those that come in by the door; those that come in by the window.." -- Tuco, "
RMPIA
By

Doug Kass

 | May 8, 2017 | 4:38 PM EDT
"She's a witch of trouble in electric blue, In her own mad mind she's in love with you. With you. Now what you gonna do? Strange brew, kill w …
By

Bret Jensen

 | Apr 28, 2017 | 2:11 PM EDT
Been two fairly uneventful days of trading, as far as the market indexes go, sitting in for Doug Kass here on the Daily Diary. Major indices are slightly down as we head into the last two hours of the trading week.
Ahead of Wednesday's earnings report(pre open)GD is on its way to its best close of the ye...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.